Antiatherogenic role of high-density lipoproteins: insights from genetically engineered-mice

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Research

Background:

• Plasma high-density lipoprotein (HDL) cholesterol levels inversely correlate with atherosclerotic cardiovascular disease incidence.
• HDL's cardioprotective effects are linked to reverse cholesterol transport (RCT), antioxidant properties, and endothelial function.
• In vivo human verification of these HDL functions remains limited.

Purpose of the Study:

• To review novel insights into the molecular mechanisms of HDL's antiatherogenic functions.
• To focus on macrophage-dependent RCT, antioxidant properties, and endothelial effects.
• To highlight findings from genetically engineered mouse models.

Main Methods:

• Review of studies utilizing genetically engineered mice.
• Analysis of molecular mechanisms underlying HDL's antiatherogenic functions.
• In vivo investigation of HDL's role in atherogenesis.

Main Results:

• Genetically engineered mice have provided significant new information on HDL's antiatherogenic functions.
• Detailed analysis revealed molecular mechanisms controlling key HDL functions in vivo.
• Insights into HDL's role in reverse cholesterol transport, antioxidant activity, and endothelial function were elucidated.

Conclusions:

• Genetically engineered mice are crucial for understanding HDL's in vivo mechanisms.
• Novel molecular insights into HDL's antiatherogenic functions have been uncovered.
• Further research in vivo is essential to validate HDL's protective effects against cardiovascular disease.